⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for renal dialysis

Every month we try and update this database with for renal dialysis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary HyperparathyroidismNCT01254565
Secondary Hyper...
Etelcalcetide
Placebo
18 Years - KAI Pharmaceuticals
Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary HyperparathyroidismNCT01576146
Secondary Hyper...
Etelcalcetide
18 Years - KAI Pharmaceuticals
Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary HyperparathyroidismNCT01134562
Hyperparathyroi...
Placebo
Etelcalcetide
18 Years - KAI Pharmaceuticals
Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary HyperparathyroidismNCT01576146
Secondary Hyper...
Etelcalcetide
18 Years - KAI Pharmaceuticals
Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary HyperparathyroidismNCT01134562
Hyperparathyroi...
Placebo
Etelcalcetide
18 Years - KAI Pharmaceuticals
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: